Skip to content
★ Sign in to follow
LC

LAMEDITECH Co., Ltd. Stock: price and insider trades · South Korea

라메디텍

KR·Mcap ₩26.9BHealth Care

No insider purchase over the last 90 days. The latest, by 장창욱, was filed 25 Sept 2025.

LAMEDITECH Co., Ltd.: what insiders have been doing

This page follows insider dealings at LAMEDITECH Co., Ltd. as filed with DART (FSS), a company from the Health Care sector. Over the twelve months to 10 November 2026, 1 filing were filed, from 1 insider.

No insider bought on the market over the period, while 1 insider filed 1 sale. No amount is published for 1 filing, which the totals therefore leave out.

Across the 2,630 companies tracked on its exchange, the median is 7 filings; at 1 filing, this issuer sits below that mark. Since 2024, the database holds 10 purchases and 1 sale by insiders of the company.

A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
10 ops. · all time
Sell Volume
n/a
1 ops. · all time

Who traded when

BuySale
장창욱1 buy
최종석1 sale
Fundamental score
Ranked 24,769 of 26,911 companies
19.4
score / 100
Value
5
Quality
34
FCF yld-58%
Earn yld-43%
EV/EBITDA·
ROE-102%
Gross mgn44%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩3,060
Analyst consensus
·
Income statement
Revenue₩7.2B
Gross profit₩3.1B44% margin
EBITDA-₩10.6B-147% margin
Net income-₩11.4B-175.4% margin
Valuation
Beta0.20
Balance sheet & cash
Market cap₩26.9B
Total debt₩7.3B
Free Cash Flow-₩15.3B
Debt / Equity154%
Profitability & ownership
ROE-102.2%
ROA-33.2%
% insiders39.1%
% institutions11.5%
Last declaration on 24 June 2026
Declarations11 total
  • ▼
    대량보유자Executives(filed)
    0DART
    131,520 sharesKRXDART:20260624000286
  • ▲
    Executives
    0DART
    32,000 sharesShareKRXDART:20250925000272
    Canonical exit: 18 Dec 2025 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    996,500 sharesKRXDART:20240624000172
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    상무이사Executives
    0DART
    ShareKRXDART:20240620000412
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    Executives
    0DART
    600,000 sharesKRXDART:20240621000241
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    기타비상무이사Executives
    0DART
    ShareKRXDART:20240621000197
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    CFO/전무이사Executives
    0DART
    ShareKRXDART:20240621000069
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    상무이사Executives
    0DART
    ShareKRXDART:20240621000037
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    대표이사Executives
    0DART
    ShareKRXDART:20240621000044
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    이사Executives
    0DART
    ShareKRXDART:20240621000134
    Canonical exit: 15 Sept 2024 (T+90)
  • ▲
    Executives
    0DART
    2,881,050 sharesKRXDART:20240620000403
    Canonical exit: 15 Sept 2024 (T+90)

11 of 11 declarations

About LAMEDITECH Co., Ltd.

The company 라메디텍 operates in the healthcare and pharmaceutical sector. It is listed on the XKRX market.